Data / Form D filings / SISCAPA Assay Technologies, Inc.
SISCAPA Assay Technologies, Inc.: Form D filings
SISCAPA Assay Technologies, Inc., a biotechnology company in Washington, DC, filed 3 Form D notices with the SEC between 2012 and 2025. The latest, on August 28, 2025, reports $2 million sold of a $2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1759 WILLARD ST NW, Washington, DC, 20009
- Phone
- (301) 728-1451
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1528248
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | New notice | $1,999,940 | $1,999,940 | 1 | Apr 29, 2025 | sec.gov | |
| Apr 11, 2014 | New notice | $1,000,000 | $1,000,000 | 8 | Apr 11, 2014 | sec.gov | |
| Aug 23, 2012 | New notice | $1,560,000 | $562,000 | $998,000 | 6 | Aug 13, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Constance L. Seniff | Executive Officer, Director | |
| Terry W. Pearson | Director | |
| Norman Liegh Anderson | Executive Officer, Director | |
| Gus W. Salem | Director |
Other biotechnology companies in District of Columbia that filed recently
- OptoVista Holdings, LLC $3.7 million · Sep 25, 2026
Every Form D from the week of Aug 25, 2025 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SISCAPA Assay Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.